Claudin-Low Breast Cancer; Clinical & Pathological Characteristics

• Kay Dias,

  Affiliations Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada, Department of Oncology, McMaster University, Hamilton, Ontario, Canada

  ⨯
• Anna Dvorkin-Gheva,

  Affiliation Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada

  ⨯
• Robin M. Hallett,

  Affiliation Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada

  ⨯
• Ying Wu,

  Affiliation Department of Oncology, McMaster University, Hamilton, Ontario, Canada

  ⨯
• John Hassell,

  Affiliations Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada

  ⨯
• Gregory R. Pond,

  Affiliation Department of Oncology, McMaster University, Hamilton, Ontario, Canada

  ⨯
• Mark Levine,

  Affiliation Department of Oncology, McMaster University, Hamilton, Ontario, Canada

  ⨯
• Tim Whelan,

  Affiliation Department of Oncology, McMaster University, Hamilton, Ontario, Canada

  ⨯
• Anita L. Bane

  * E-mail: bane@hhsc.ca

  Affiliations Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada, Department of Oncology, McMaster University, Hamilton, Ontario, Canada

  ⨯